RFG
IRWD icon

Range Financial Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Range Financial Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.2K Sell
12,868
-420,388
-97% -$1.62M 0.01% 205
2026
Q1 		$1.52M Buy
433,256
+7,161
+2% +$29.4K 0.51% 67
2025
Q4 		$1.44M Buy
+426,095
New +$1.11M 0.5% 68

Other funds holding IRWD

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Range Financial Group's IRWD Position: Q2 2026 in Review

Range Financial Group reduced its Ironwood Pharmaceuticals (IRWD) stake by 97% in Q2 2026, selling an estimated $1.62M and leaving 12,868 shares worth $54.2K. The position accounts for 0.01% of the portfolio, ranked #205.

Range Financial Group first reported a position in IRWD in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.52M in Q1 2026. 14 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Range Financial Group held 12,868 shares of Ironwood Pharmaceuticals worth $54.2K as of Q2 2026.
  • Range Financial Group sold 420,388 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $1.62M.
  • Ironwood Pharmaceuticals made up 0.01% of Range Financial Group's portfolio in Q2 2026, its #205 holding.
  • Range Financial Group first reported a position in Ironwood Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Range Financial Group's Ironwood Pharmaceuticals position peaked at $1.52M in Q1 2026.
  • 14 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Range Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.